INSULIN. - PowerPoint PPT Presentation

About This Presentation
Title:

INSULIN.

Description:

BIOCHEMISTRY – PowerPoint PPT presentation

Number of Views:1629
Slides: 22
Provided by: m.prasadnaidu
Tags: good

less

Transcript and Presenter's Notes

Title: INSULIN.


1
Insulin oral hypoglycaemic
  • M.Prasad Naidu
  • MSc Medical Biochemistry, Ph.D,.

2
Diabetes mellitus - It is a group of
heterogenous disorder in which carbohydrate
metabolism is ?, while that of proteins lipids
are ?. Types - Type I - insulin dependent
DM Type II non insulin dependent DM Type III
DM occurs by other disorders Type IV
gestational DM
3
Insulin - Chemistry , biosynthesis secretion
- Chemistry - Insulin is made up of 86
aminoacids , It contain A chain 21 AA, B chain
30 AA, Connecitng Peptide 35 AA. Biosynthesis
- Preproinsulin proinsulin Insulin
C peptide Secretion - Glucose transport to ß
cell by GLUT 2 glucose transporter, it undergoes
further metabolism, it generated ATP. Which
inhibit the activity of K CHANNELS. The
inhibition of K channel induces ß cell membrane
depolarisation, opening of voltage dependent Ca2
channel stimulates insulin secretion.
4
(No Transcript)
5
  • Pharmacological actions -
  • Carbohydrate metabolism
  • ?glycogenesis ? glycogenolysis
  • Protein metabolism
  • ? protein break down ?
  • Fat metabolism
  • ? lipogenesis ?fatty acid synthesis.

6
(No Transcript)
7
Newer insulin preparations Insulin
syringes Portable pen injections Insulin
pumps Biodegradable microspheres Inhaled
insulins Therapeutic uses - Type 1 diabetes
NPH Regular Insulin Type 2 diabetes - Regular
Insulin Diabetic ketoacidosis Tr. IV fluids,
Kcl, sodium bicarbonate, phoshate Non
ketonic hyperglycemic Emergency treatment of
hyperkalaemia
8
  • Adverse effects -
  • Hypoglycaemia
  • Lipodystrophy
  • Allergic manifestation
  • Insulin resistance
  • Edema

9
Oral hypoglycaemic drugs - Classification
- Sulfonylureas 1st generation -
Tolbutamide Chlorpropamide 2nd generation
Glibenclamide Glipizide Gliclazide Glime
piride Meglitinide analogues - Repaglinide Nate
glinide
10
Biguanides - Metformin Phenformin Alfa
glucosidase inhibitors - Acarbose Miglitol Thia
zolidinediones Rosiglitazone Pioglitazone
11
Sulfonylureas - MOA - Sulfonylureas acts on
beta cells, stimulating insulin secretion and
thus reducing blood glucose levels. Drugs reuce
the permeability of K by competitively blocking
the sulfonylureas receptors present on ATP
sensitive K channels , causing depolarisation,
Ca2 entry and insulin secretion. Adverse
effects - Hypoglycaemia Weight gain, nausea,
vomiting, diarrhoea, constipation ,
agranulocytosis, hypersensitivity, cholestatic
jaundice.
12
PK - Absorbed orally, high plasma protein
bindint(90-98) Metabolized in liver , excreted
in urine Duration of action 6-12 hr It croses
placental barrier it caused hypoglycaemia at
birth CI - Pregnancy Gestational diabetes
13
Drug interactions - Drugs that potentiate the
effects of sulfonylureas Oral anticoagulants,
ketoconazole, chloramphenicol (-) metabolism
Salicylates, sulfonamides , clofibrate
displace protein binding sites Drugs that
decrease the effects of sulfonylurease
Phenobarbitone, phenytoin , rifampicin
decrease metabolism corticosteroids, thiadides,
estrogens - Biguanides - ? uptake and
utilization of glucose in skeletal muscle reduce
insulin resistant (-) renal hepatic
gluconeogenesis ? glucose absorption from GIT ?
Plasma glucagon levels
14
Corticosteroids
Classification
- Glucocorticoids Short acting
Hydrocortisone Intermediate acting
Prednisolone Methyl
prednisolone
Triamcinolone Long acting - Betamethasone
Dexamethasone Meneralocorticoids
- Desoxycorticosterone acetate Fludrocortisone
aldosterone
15
Mechanism of actions - Corticoids bind to
specific receptor in the cytoplasm , the drug
Receptor complex is transported into the
nucleous where it binds to specific Sites on DNA
and regulates the synthesis of new proteins that
bring about The hormone effects
. Pharmacological actions - Mineralocorticoids
highly effects on Na, k and fluid
balance Glucocorticoids highly effects on
carbohydrate, protein, fat and other. Metabolic
effects - Carbohydrate promote
gluconeogenesis Protein- enhance protein break
down Fat lipolysis, redistribution of fat
16
Antiinflammatory and immunosuppressive effects
- Supress development of inflammatory response
to all types of stimuli inhibit bothLate and
early manifestations of inflammation. Supress
cell mediated immunity, prevent manifestations of
allergy Ca 2 metabolism (-) intestinal
absorption enhance renal excretion of ca2 CVS
- Skeletal muscle - hypocritism,
hypercritism CNS - euphoria Stomach - increase
gastric secretion Lymphoid tissue and blood cells
- increase destruction of lymphoid cells,
increase no. of RBC, neutrophils, platelets.

17
  • Therapeutic uses -
  • Replacement therapy
  • Acute adrenal insufficiency
  • Chronic adrenal insufficiency
  • Congenital adrenal hyperplasia
  • Pharmacotherapy
  • Arthritides NSAIDS glucocorticoids
  • Rheumatoid arthritis
  • Osteoarthritis
  • Rheumatic fever
  • Gout
  • Collagen diseases SLE, nephrotic syndrome,
    glomerulonethritis
  • Severe allergic reactions angioneuotic edema,
    urticaria and serum sickness

18
  • Autoimmune diseases haemolytic anaemia,
    thrombocytopenia,
  • chronic hepatitis
  • Bronchial asthma status asthmaticus, acute
    asthma excerbation
  • Other lung diseases Pulmonary edema
    aspiration penumonia
  • Infective diseases tuberculosis, severe
    lepra reaction
  • Eye diseases keratitis, iridocyclitis,
    iritis, allergic conjuctivitis, prevent
    blindness
  • Skin diseases exfoliative dermatitis,
    stevens hohnson syndrome
  • Intestinal diseases ulcerative colitis,
    coeliac disease
  • Cerebral edema
  • Malignancies acute lymphatic leukemia,
    hodgkins breast carcinoma
  • Organ transplantation and skin allograft
    liver, kidney, heart transplantation.
  • Shock

19
  • Adverse effects -
  • Mineralocorticoids hypokalemic alkalosis,
    edema, raise in BP
  • Glucocorticoids -
  • Cushings habitus
  • Hyperglycaemia
  • Muscular weakness
  • Delayed healing
  • Peptic ulceration
  • Osteoporosis
  • Galucoma
  • Growth retardation
  • Foetal abnormalities

20
  • Psychiatric disturbances
  • Suppression of hypothalamo pituitary adrenal
    axis
  • Fragile skin , purple striae
  • Contraindications -
  • Peptic ulcer
  • DM
  • HT
  • Viral and fungal infections
  • Tuberculosis other infections
  • Osteoporosis
  • Psychosis
  • Epilepsy
  • CHF
  • Renal failure

21
THANK U
Write a Comment
User Comments (0)
About PowerShow.com